Source: Eur Respir J 2007; 30: 191-193
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sathyapala S. A., Kemp P., Polkey M. I.. Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?. Eur Respir J 2007; 30: 191-193

Member's Comments

No comment yet.

Related content which might interest you: Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting Source: Annual Congress 2008 - Respiratory muscle pathophysiology Year: 2008 Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Altered muscle metabolism and muscle mass in patients with COPD Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases Year: 2017 Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD Source: Eur Respir J 2003; 22: 88-93 Year: 2003 Mitochondrial functional alterations in COPD locomotor muscle are independent of cachexia and fiber type shift Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014 Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Muscle morphology, metabolism and muscle function: general principles Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=86 Year: 2003 Increased autophagy and reduced protein synthesis signaling are involved in pulmonary inflammation-induced skeletal muscle atrophy Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Impaired myogenesis in the quadriceps muscle of cachectic COPD patients Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function Year: 2014 Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD Source: Annual Congress 2006 - Respiratory muscles Year: 2006 The association of vitamine D deficiency and skeletal muscle dysfunction in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Impaired skeletal muscle kynurenine metabolism in patients with COPD Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Permeabilized skeletal muscle fiber technique: a tool to unravel energy metabolism dysfunction in myopathy during chronic lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 393s Year: 2003 Features of skeletal muscle dysfunction in COPD patients with obesity Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Hypoxia induces differential acute and chronic adaptations in regulation of skeletal muscle protein turnover Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011 Skeletal muscle inflammatory markers in COPD patients with muscle wasting Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 The clinical impact of skeletal muscle dysfunction Source: Annual Congress 2008 - PG3 - Respiratory physiology: respiratory and peripheral muscle function in health and disease Year: 2008